Neonc Technologies (NASDAQ:NTHI) President Purchases $121,800.00 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Amir Heshmatpour bought 20,000 shares of Neonc Technologies stock in a transaction on Thursday, April 2nd. The shares were purchased at an average cost of $6.09 per share, for a total transaction of $121,800.00. Following the acquisition, the president owned 3,012,000 shares in the company, valued at $18,343,080. The trade was a 0.67% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Neonc Technologies Stock Down 7.7%

NASDAQ:NTHI opened at $5.37 on Thursday. The business’s 50 day moving average is $8.71 and its two-hundred day moving average is $9.15. Neonc Technologies Holdings, Inc. has a 52 week low of $3.20 and a 52 week high of $12.99.

Institutional Trading of Neonc Technologies

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. HighPoint Advisor Group LLC raised its position in shares of Neonc Technologies by 20.5% during the 4th quarter. HighPoint Advisor Group LLC now owns 1,144,640 shares of the company’s stock worth $9,466,000 after purchasing an additional 194,408 shares during the period. Bank of America Corp DE raised its position in shares of Neonc Technologies by 1.0% during the 3rd quarter. Bank of America Corp DE now owns 226,486 shares of the company’s stock worth $2,056,000 after purchasing an additional 2,207 shares during the period. Vanguard Group Inc. acquired a new stake in Neonc Technologies in the 3rd quarter valued at approximately $1,279,000. 683 Capital Management LLC acquired a new stake in Neonc Technologies in the 4th quarter valued at approximately $442,000. Finally, Global Retirement Partners LLC acquired a new stake in Neonc Technologies in the 3rd quarter valued at approximately $434,000.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neonc Technologies in a report on Friday, March 27th. Zacks Research upgraded Neonc Technologies to a “hold” rating in a research report on Wednesday, January 14th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Reduce”.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.